Volume 86, issue 9, Septembre 1999

Articles originaux

Decision committees in oncology: from standard to actual cases (p.767-72)
Catherine Sauvagnac, Véronique Beckendorf, Anne Lesur, Elizabeth Luporsi, Joseph Stines, Pierre Falzon, Pierre Bey

Endothelin receptors in benign human tumours of uterine muscle (p.773-8)
Michelle Breuiller-Fouché, Jean-Claude Honoré, Brigitte Robert, Thérèse Fournier, Marie-Cécile Vacher-Lavenu, Charles Chapron, Jean-Bernard Dubuisson, Françoise Ferré

Synthèses

Bisphosphonates and bone metastases (p.732-8)
Alain Lortholary, Eric Jadaud, Patrice Berthaud

Adult’s anaplastic CD30+ large cell lymphomas (p.739-44)
Laurent Cany, Pierre Soubeyran, Vincent Boulanger, Isabelle Soubeyran, Pierre Richaud, Houchingue Eghbali, Bernard Hoerni

Initial medical treatment for breast cancer (p.745-52)
Etienne C.G. Brain, Jean-Louis Misset, Jacques Rouëssé

Point sur…

Multiple actions of EGCG, the main component of green tea (p.721-4)
Gilles L’Allemain

beta-catenin mutations in a common skin cancer : pilomatricoma (p.725-6)
Matthieu Durand, Jean-Pierre Molès

A multitargeted antifolate (MTA) (p.727-31)
Amélie Lansiaux, Marian Degardin, Christian Bailly

Débat : Mastectomie prophylactique ?

The goals and limits of the debat (p.753)
Nicolas Janin, Dominique Stoppa-Lyonnet

Under what conditions should we propose a prophylactic mastectomy for a woman at risk? (p.754-9)
Marion Gauthier-Villars, Cécile Blandy, Dominique Stoppa-Lyonnet

For what reasons should we avoid suggesting a prophylactic mastectomy for a woman at risk? (p.760-6)
Nicolas Janin

Compte rendu de congrès

35th annual meeting of the ASCO (p.779-81)
Laurent Zelek, Marc Spielmann, Jean-Philippe Metges

Second annual meeting of the American Society of Gene Therapy (ASGT) (p.782-6)
Mireia Pelegrin